Switch to:

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 8/10

vs
industry
vs
history
Cash to Debt 1.10
A's Cash to Debt is ranked lower than
53% of the 2553 Companies
in the Global Scientific & Technical Instruments industry.

( Industry Median: 4.05 vs. A: 1.10 )
A' s 10-Year Cash to Debt Range
Min: 0.63   Max: No Debt
Current: 1.1

Equity to Asset 0.51
A's Equity to Asset is ranked higher than
54% of the 2528 Companies
in the Global Scientific & Technical Instruments industry.

( Industry Median: 0.56 vs. A: 0.51 )
A' s 10-Year Equity to Asset Range
Min: 0.31   Max: 0.71
Current: 0.51

0.31
0.71
Interest Coverage 8.89
A's Interest Coverage is ranked lower than
58% of the 1546 Companies
in the Global Scientific & Technical Instruments industry.

( Industry Median: 82.18 vs. A: 8.89 )
A' s 10-Year Interest Coverage Range
Min: 0.53   Max: 9999.99
Current: 8.89

0.53
9999.99
F-Score: 6
Z-Score: 4.07
M-Score: -2.72
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 8/10

vs
industry
vs
history
Operating margin (%) 14.02
A's Operating margin (%) is ranked higher than
92% of the 2528 Companies
in the Global Scientific & Technical Instruments industry.

( Industry Median: 3.72 vs. A: 14.02 )
A' s 10-Year Operating margin (%) Range
Min: -26.74   Max: 16.32
Current: 14.02

-26.74
16.32
Net-margin (%) 10.68
A's Net-margin (%) is ranked higher than
89% of the 2529 Companies
in the Global Scientific & Technical Instruments industry.

( Industry Median: 3.04 vs. A: 10.68 )
A' s 10-Year Net-margin (%) Range
Min: -33.98   Max: 66.5
Current: 10.68

-33.98
66.5
ROE (%) 13.70
A's ROE (%) is ranked higher than
87% of the 2498 Companies
in the Global Scientific & Technical Instruments industry.

( Industry Median: 5.76 vs. A: 13.70 )
A' s 10-Year ROE (%) Range
Min: -72.88   Max: 90.65
Current: 13.7

-72.88
90.65
ROA (%) 6.78
A's ROA (%) is ranked higher than
83% of the 2534 Companies
in the Global Scientific & Technical Instruments industry.

( Industry Median: 2.87 vs. A: 6.78 )
A' s 10-Year ROA (%) Range
Min: -32.68   Max: 44.88
Current: 6.78

-32.68
44.88
ROC (Joel Greenblatt) (%) 51.68
A's ROC (Joel Greenblatt) (%) is ranked higher than
95% of the 2526 Companies
in the Global Scientific & Technical Instruments industry.

( Industry Median: 11.30 vs. A: 51.68 )
A' s 10-Year ROC (Joel Greenblatt) (%) Range
Min: -66.02   Max: 73.16
Current: 51.68

-66.02
73.16
Revenue Growth (%) 8.40
A's Revenue Growth (%) is ranked higher than
80% of the 1846 Companies
in the Global Scientific & Technical Instruments industry.

( Industry Median: 2.40 vs. A: 8.40 )
A' s 10-Year Revenue Growth (%) Range
Min: -18.5   Max: 14.8
Current: 8.4

-18.5
14.8
EBITDA Growth (%) 11.50
A's EBITDA Growth (%) is ranked higher than
79% of the 1498 Companies
in the Global Scientific & Technical Instruments industry.

( Industry Median: 2.10 vs. A: 11.50 )
A' s 10-Year EBITDA Growth (%) Range
Min: -27.7   Max: 76.8
Current: 11.5

-27.7
76.8
EPS Growth (%) 2.70
A's EPS Growth (%) is ranked higher than
68% of the 1348 Companies
in the Global Scientific & Technical Instruments industry.

( Industry Median: 2.50 vs. A: 2.70 )
A' s 10-Year EPS Growth (%) Range
Min: 2.7   Max: 135.6
Current: 2.7

2.7
135.6
» A's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow

» Details

Guru Trades

Q3 2013

A Guru Trades in Q3 2013

Joel Greenblatt 20,773 sh (New)
George Soros 24,425 sh (New)
John Hussman 157,000 sh (New)
Steven Cohen 234,129 sh (+238.01%)
Sarah Ketterer 848,520 sh (+46.15%)
George Soros 17,500 sh (unchged)
Caxton Associates 600,000 sh (unchged)
Ron Baron 26,000 sh (unchged)
Brian Rogers 2,250,000 sh (unchged)
Louis Moore Bacon Sold Out
Scott Black Sold Out
Richard Perry Sold Out
Jean-Marie Eveillard Sold Out
PRIMECAP Management 94,709 sh (-1.25%)
Chris Davis 3,625,285 sh (-1.47%)
Richard Snow 1,316,336 sh (-4.27%)
Vanguard Health Care Fund 5,899,000 sh (-8.06%)
Pioneer Investments 114,902 sh (-20.1%)
Robert Olstein 125,000 sh (-22.36%)
Paul Tudor Jones 251,300 sh (-22.68%)
David Dreman 1,991 sh (-97.37%)
» More
Q4 2013

A Guru Trades in Q4 2013

Caxton Associates 43,510 sh (New)
Jim Simons 276,700 sh (New)
John Hussman 313,000 sh (+99.36%)
George Soros 17,500 sh (unchged)
Ron Baron 26,000 sh (unchged)
Caxton Associates 60,000 sh (unchged)
George Soros 24,425 sh (unchged)
Joel Greenblatt Sold Out
Paul Tudor Jones Sold Out
Sarah Ketterer Sold Out
PRIMECAP Management 94,609 sh (-0.11%)
Chris Davis 3,585,021 sh (-1.11%)
Vanguard Health Care Fund 5,624,200 sh (-4.66%)
Pioneer Investments 108,367 sh (-5.69%)
Richard Snow 1,204,695 sh (-8.48%)
Robert Olstein 85,000 sh (-32%)
Brian Rogers 1,497,454 sh (-33.45%)
David Dreman 550 sh (-72.38%)
Steven Cohen 45,324 sh (-80.64%)
» More
Q1 2014

A Guru Trades in Q1 2014

Paul Tudor Jones 6,156 sh (New)
Signature Select Canadian Fund 191,600 sh (New)
David Dreman 2,134 sh (+288%)
Steven Cohen 128,546 sh (+183.62%)
Ron Baron 26,000 sh (unchged)
Caxton Associates 60,000 sh (unchged)
Vanguard Health Care Fund 5,624,200 sh (unchged)
John Hussman 313,000 sh (unchged)
Robert Olstein Sold Out
Jim Simons Sold Out
George Soros Sold Out
Caxton Associates Sold Out
Brian Rogers Sold Out
Pioneer Investments Sold Out
PRIMECAP Management 94,009 sh (-0.63%)
Chris Davis 3,246,884 sh (-9.43%)
Richard Snow 649,036 sh (-46.12%)
» More
Q2 2014

A Guru Trades in Q2 2014

Jean-Marie Eveillard 831,224 sh (New)
John Keeley 46,640 sh (New)
Paul Tudor Jones 128,579 sh (+1988.68%)
David Dreman 2,332 sh (+9.28%)
Vanguard Health Care Fund 5,624,200 sh (unchged)
Ron Baron 26,000 sh (unchged)
Richard Snow Sold Out
John Hussman Sold Out
PRIMECAP Management 91,717 sh (-2.44%)
Chris Davis 2,991,923 sh (-7.85%)
» More
» Details

Insider Trades

Latest Guru Trades with A

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

GuruDate Trades Impact to Portfolio Price Range * (?) Current Price Change from Average Current Shares
John Hussman 2014-06-30 Sold Out 1.3%$52.65 - $59.28 $ 58.564%0
Jean-Marie Eveillard 2014-06-30 New Buy0.12%$52.65 - $59.28 $ 58.564%831224
John Keeley 2014-06-30 New Buy0.05%$52.65 - $59.28 $ 58.564%46640
George Soros 2014-03-31 Sold Out 0.01%$54.69 - $60.93 $ 58.562%0
David Dreman 2014-03-31 Add 288%0.01%$54.69 - $60.93 $ 58.562%2134
John Hussman 2013-12-31 Add 99.36%0.65%$49.95 - $57.89 $ 58.5610%313000
Joel Greenblatt 2013-12-31 Sold Out 0.04%$49.95 - $57.89 $ 58.5610%0
David Dreman 2013-12-31 Reduce -72.38%0.01%$49.95 - $57.89 $ 58.5610%550
Richard Perry 2013-09-30 Sold Out 1.6%$43.09 - $52.15 $ 58.5624%0
Scott Black 2013-09-30 Sold Out 0.75%$43.09 - $52.15 $ 58.5624%0
John Hussman 2013-09-30 New Buy0.44%$43.09 - $52.15 $ 58.5624%157000
David Dreman 2013-09-30 Reduce -97.37%0.11%$43.09 - $52.15 $ 58.5624%1991
Joel Greenblatt 2013-09-30 New Buy0.04%$43.09 - $52.15 $ 58.5624%20773
Jean-Marie Eveillard 2013-09-30 Sold Out 0.04%$43.09 - $52.15 $ 58.5624%0
George Soros 2013-09-30 New Buy0.01%$43.09 - $52.15 $ 58.5624%24425
Premium More recent guru trades are included for Premium Members only!!
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Top Ranked Articles about Agilent Technologies Inc

Brian Rogers Changes His Mind on Apple at Lower Valuation
Back in March 2012, when many firms were cashing in on Apple (AAPL)’s astronomical growth, Bloomberg noted that the stock was “conspicuously absent” from Brian Rogers’ portfolio. Rogers, the chairman and chief investment officer overseeing $500 billion at T. Rowe Price, responded at the time that Apple was not right for his firm’s value funds. A little while later, he did an about-face on the stock, taking a large position and adding shares as recently as the third quarter. Read more...

Ratios

vs
industry
vs
history
P/E(ttm) 28.10
A's P/E(ttm) is ranked higher than
64% of the 2666 Companies
in the Global Scientific & Technical Instruments industry.

( Industry Median: 30.20 vs. A: 28.10 )
A' s 10-Year P/E(ttm) Range
Min: 3.84   Max: 67.48
Current: 28.1

3.84
67.48
P/B 3.30
A's P/B is ranked lower than
60% of the 2666 Companies
in the Global Scientific & Technical Instruments industry.

( Industry Median: 1.70 vs. A: 3.30 )
A' s 10-Year P/B Range
Min: 1.7   Max: 5.48
Current: 3.3

1.7
5.48
P/S 2.90
A's P/S is ranked lower than
73% of the 2666 Companies
in the Global Scientific & Technical Instruments industry.

( Industry Median: 0.93 vs. A: 2.90 )
A' s 10-Year P/S Range
Min: 0.83   Max: 3.84
Current: 2.9

0.83
3.84
PFCF 21.20
A's PFCF is ranked higher than
74% of the 2666 Companies
in the Global Scientific & Technical Instruments industry.

( Industry Median: 88.59 vs. A: 21.20 )
A' s 10-Year PFCF Range
Min: 7.53   Max: 89.57
Current: 21.2

7.53
89.57
EV-to-EBIT 18.96
A's EV-to-EBIT is ranked higher than
69% of the 2666 Companies
in the Global Scientific & Technical Instruments industry.

( Industry Median: 23.95 vs. A: 18.96 )
A' s 10-Year EV-to-EBIT Range
Min: 7.7   Max: 256.8
Current: 18.96

7.7
256.8
PEG 0.60
A's PEG is ranked higher than
95% of the 2666 Companies
in the Global Scientific & Technical Instruments industry.

( Industry Median: 9999.00 vs. A: 0.60 )
A' s 10-Year PEG Range
Min: 0.23   Max: 37.37
Current: 0.6

0.23
37.37
Shiller P/E 27.70
A's Shiller P/E is ranked higher than
87% of the 2666 Companies
in the Global Scientific & Technical Instruments industry.

( Industry Median: 9999.00 vs. A: 27.70 )
A' s 10-Year Shiller P/E Range
Min: 8.91   Max: 121.81
Current: 27.7

8.91
121.81
Current Ratio 3.13
A's Current Ratio is ranked higher than
80% of the 1843 Companies
in the Global Scientific & Technical Instruments industry.

( Industry Median: 1.98 vs. A: 3.13 )
A' s 10-Year Current Ratio Range
Min: 1.61   Max: 3.53
Current: 3.13

1.61
3.53
Quick Ratio 2.49
A's Quick Ratio is ranked higher than
81% of the 1843 Companies
in the Global Scientific & Technical Instruments industry.

( Industry Median: 1.45 vs. A: 2.49 )
A' s 10-Year Quick Ratio Range
Min: 1.04   Max: 3.04
Current: 2.49

1.04
3.04

Dividend & Buy Back

vs
industry
vs
history
Dividend Yield 0.90
A's Dividend Yield is ranked lower than
73% of the 1680 Companies
in the Global Scientific & Technical Instruments industry.

( Industry Median: 1.65 vs. A: 0.90 )
A' s 10-Year Dividend Yield Range
Min: 0.22   Max: 1.02
Current: 0.9

0.22
1.02
Dividend Payout 0.24
A's Dividend Payout is ranked higher than
84% of the 2666 Companies
in the Global Scientific & Technical Instruments industry.

( Industry Median: 9999.00 vs. A: 0.24 )
A' s 10-Year Dividend Payout Range
Min: 0.09   Max: 0.32
Current: 0.24

0.09
0.32
Yield on cost (5-Year) 0.90
A's Yield on cost (5-Year) is ranked lower than
74% of the 1736 Companies
in the Global Scientific & Technical Instruments industry.

( Industry Median: 1.88 vs. A: 0.90 )
A' s 10-Year Yield on cost (5-Year) Range
Min: 0.22   Max: 1.02
Current: 0.9

0.22
1.02
Share Buyback Rate 0.80
A's Share Buyback Rate is ranked higher than
86% of the 1328 Companies
in the Global Scientific & Technical Instruments industry.

( Industry Median: -1.00 vs. A: 0.80 )
A' s 10-Year Share Buyback Rate Range
Min: 9.5   Max: -7
Current: 0.8

Valuation & Return

vs
industry
vs
history
Price/Tangible Book 11.30
A's Price/Tangible Book is ranked lower than
76% of the 2666 Companies
in the Global Scientific & Technical Instruments industry.

( Industry Median: 2.10 vs. A: 11.30 )
A' s 10-Year Price/Tangible Book Range
Min: 1.54   Max: 17.47
Current: 11.3

1.54
17.47
Price/DCF (Projected) 1.20
A's Price/DCF (Projected) is ranked higher than
87% of the 2666 Companies
in the Global Scientific & Technical Instruments industry.

( Industry Median: 9999.00 vs. A: 1.20 )
A' s 10-Year Price/DCF (Projected) Range
Min: 0.88   Max: 4.09
Current: 1.2

0.88
4.09
Price/Median PS Value 1.30
A's Price/Median PS Value is ranked higher than
54% of the 2666 Companies
in the Global Scientific & Technical Instruments industry.

( Industry Median: 1.10 vs. A: 1.30 )
A' s 10-Year Price/Median PS Value Range
Min: 0.44   Max: 1.65
Current: 1.3

0.44
1.65
Price/Peter Lynch Fair Value 1.10
A's Price/Peter Lynch Fair Value is ranked higher than
94% of the 2666 Companies
in the Global Scientific & Technical Instruments industry.

( Industry Median: 9999.00 vs. A: 1.10 )
A' s 10-Year Price/Peter Lynch Fair Value Range
Min: 0.42   Max: 6.85
Current: 1.1

0.42
6.85
Price/Graham Number 3.70
A's Price/Graham Number is ranked higher than
50% of the 2666 Companies
in the Global Scientific & Technical Instruments industry.

( Industry Median: 2.50 vs. A: 3.70 )
A' s 10-Year Price/Graham Number Range
Min: 1.08   Max: 4.86
Current: 3.7

1.08
4.86
Earnings Yield (Greenblatt) 5.10
A's Earnings Yield (Greenblatt) is ranked higher than
56% of the 2220 Companies
in the Global Scientific & Technical Instruments industry.

( Industry Median: 6.50 vs. A: 5.10 )
A' s 10-Year Earnings Yield (Greenblatt) Range
Min: 0.4   Max: 13
Current: 5.1

0.4
13
Forward Rate of Return (Yacktman) 36.65
A's Forward Rate of Return (Yacktman) is ranked higher than
96% of the 1587 Companies
in the Global Scientific & Technical Instruments industry.

( Industry Median: 3.04 vs. A: 36.65 )
A' s 10-Year Forward Rate of Return (Yacktman) Range
Min: -1.3   Max: 39.3
Current: 36.65

-1.3
39.3

Business Description

Industry: Computer Hardware » Scientific & Technical Instruments
Compare:ROP, GRMN, HXGBY, TRMB, NANO » details
Traded in other countries:AG8.Germany
Agilent Technologies, Inc. was incorporated in Delaware in May 1999. The Company is a measurement company, providing core bio-analytical and electronic measurement solutions to the life sciences, chemical analysis, communications and electronics industries. The four operating segments are Life sciences business, Chemical Analysis Business, Diagnostics and Genomics Business and Electronic Measurement Business. Life sciences business provides application-focused solutions that include instruments, software, consumables, and services that enable customers to identify, quantify and analyze the physical and biological properties of substances and products. Key product categories in life sciences include: liquid chromatography systems, columns and components; liquid chromatography mass spectrometry systems; laboratory software and informatics systems; laboratory automation and robotic systems; dissolution testing; nucleic acid solutions; Nuclear Magnetic Resonance ; Magnetic Resonance Imaging and X-Ray Diffraction systems and services and support for the aforementioned products. The Chemical Analysis business provides application-focused solutions that include instruments, software, consumables, and services that enable customers to identify, quantify and analyze the physical and biological properties of substances and products. Key product categories in chemical analysis include: gas chromatography systems, columns and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; software and data systems; vacuum pumps and measurement technologies; services and support for its products. Diagnostics and genomics business provides solutions that include reagents, instruments, software and consumables that enable customers in the clinical and life sciences research areas to interrogate samples at the molecular level. Its offerings include immunohistochemistry, In Situ Hybridization, Hematoxylin and Eosin Staining, special staining, DNA mutation detection, genotyping, gene copy number determination, identification of gene rearrangements, DNA methylation profiling, gene expression profiling, as well as automated gel electrophoresis-based sample analysis systems. Electronic Measurement Business provides electronic measurement instruments and systems, software design tools and related services that are used in the design, development, manufacture, installation, deployment and operation of electronics equipment, and microscopy products. Related services include start-up assistance, instrument productivity and application services and instrument calibration and repair. The Company's primary competitors are Bruker Corp., Danaher Corporation, Thermo Fisher Scientific Inc., Waters Corp, PerkinElmer Inc., Shimadzu Corporation, Ventana Me

Personalized Checklist








Within your circle of competence?
Macro economic environment favorable?
High quality business?
Enough margin of safety with stocks?
Gurus are buying?
Insiders are buying?
Management capable and shareholder friendly?
Catalyst for stock price to appreciate?
Your level of confidence with the research?

Add Notes, Comments or Ask Questions

User Comments

No comment yet

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK
Email Hide